Abstract
Current status of endocrine treatment for breast cancer is reviewed. Several new aromatase inhibitors as well as antiestrogens are being introduced for clinical trials. As different drugs within the same drug group may possess different biochemical actions, apart from being useful drugs for treatment of breast cancer, these drugs may also extend our knowledge about the endocrinology of breast cancer.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
